Trial Profile
Retrospective cohort study comparing efficacy of ertapenem against other carbapenems in treating bloodstream infections due to Extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Oct 2015
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary)
- Indications Enterobacteriaceae infections
- Focus Therapeutic Use
- 26 Oct 2015 New trial record
- 21 Sep 2015 Results presented at the Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy